DNA methylation of the protein-tyro sine phosphatase SHP1 in Philadelphia (Ph) chromosome positive chronic myelogenous leukemia (CML).

被引：0
|
作者：
Hoshino, K
Yang, H
Canalli, AA
Sanchez-Gonzalez, B
Donato, N
Kantarjian, H
Issa, JP
Garcia-Manero, G
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1528
引用
收藏
页码：420A / 421A
页数：2
相关论文
共 50 条
  • [41] Significance of Rising Levels of Minimal Residual Disease in Patients with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (Ph plus CML) in Complete Cytogenetic Response (CGCR)
    Kantarjian, Hagop M.
    Shan, Jianqin
    Jones, Dan
    O'Brien, Susan
    Rios, Mary Beth
    Jabbour, Elias
    Cortes, Jorge
    BLOOD, 2008, 112 (11) : 169 - 170
  • [42] Nilotinib in patients (pts) with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia in blast crisis (CML-BC) who are resistant or intolerant to imatinib
    Giles, Francis J.
    Larson, Richard A.
    Kantarjian, Hagop M.
    le Coutre, Philipp
    Baccarani, Michele
    Haque, Ariful
    Gallagher, Neil
    Ottmann, Oliver G.
    BLOOD, 2007, 110 (11) : 310A - 310A
  • [43] LEUKOCYTE INTERFERON TREATMENT EFFECT ON GRANULOCYTE MONOCYTE COLONY FORMING CELLS IN CHRONIC MYELOGENOUS LEUKEMIA PHILADELPHIA POSITIVE (CML PH1+) PATIENTS
    TALPAZ, M
    SPITZER, G
    HITTELMAN, W
    BERAN, M
    GUTTERMAN, JU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 273 - 273
  • [44] PH1-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA WITH ABSENCE OF ANOTHER G CHROMOSOME IN A MALE
    ENGEL, E
    JENKINS, DE
    TIPTON, RE
    MCGEE, BJ
    MONTMOLL.ME
    NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (14): : 738 - +
  • [45] DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells
    Li, Yinghua
    Liu, Xuedong
    Guo, Xiufeng
    Liu, Xiao
    Luo, Jianmin
    LEUKEMIA RESEARCH, 2017, 58 : 9 - 13
  • [46] Population pharmacokinetics of imatinib in patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase.
    Bin, P
    Schmidli, H
    Riviere, GJ
    Racine, A
    Capdeville, R
    BLOOD, 2002, 100 (11) : 784A - 784A
  • [47] A VARIANT PHILADELPHIA-CHROMOSOME (PH1) POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA
    HARUTA, Y
    TAKAHASHI, I
    SEKITO, N
    MIYAMOTO, K
    SHIMAMOTO, M
    WAKITA, Y
    KIKKAWA, K
    NAKAMURA, T
    SETO, T
    YAMASHITA, J
    YORIMITSU, S
    MIYAKE, S
    MACHIDA, K
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1990, 44 (05) : 283 - 286
  • [48] Deletions of the derivative chromosome 9 in chronic myelogenous leukemia (CML) detected by interphase fish are present only in cases with variant Philadelphia (Ph) chromosomes
    Anon, P
    Rasheed, H
    Wiggins, M
    Pickering, D
    Pavletic, S
    Foran, J
    Sanger, W
    MODERN PATHOLOGY, 2003, 16 (01) : 224A - 225A
  • [49] Deletions of the derivative chromosome 9 in chronic myelogenous leukemia (CML) detected by interphase fish are present only in cases with variant Philadelphia (Ph) chromosomes
    Aoun, P
    Rasheed, H
    Wiggins, M
    Pickering, D
    Pavletic, S
    Foran, J
    Sanger, W
    LABORATORY INVESTIGATION, 2003, 83 (01) : 224A - 225A
  • [50] The emergence of Philadelphia chromosome (Ph) negative, trisomy 8 positive cells in patients with chronic myelogenous leukemia (CML) treated with imatinib mesylate: Clinical evidence for a multistep pathogenesis.
    Feldman, EJ
    Najfeld, V
    Schuster, MW
    Roboz, GJ
    Chadburn, A
    Goodman, O
    Silver, RT
    BLOOD, 2002, 100 (11) : 585A - 585A
12345